All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Organoruthenium Complexes with CN Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68081707%3A_____%2F17%3A00486061" target="_blank" >RIV/68081707:_____/17:00486061 - isvavai.cz</a>

  • Alternative codes found

    RIV/61989592:15310/17:73583775

  • Result on the web

    <a href="http://dx.doi.org/10.1002/chem.201703581" target="_blank" >http://dx.doi.org/10.1002/chem.201703581</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/chem.201703581" target="_blank" >10.1002/chem.201703581</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Organoruthenium Complexes with CN Ligands are Highly Potent Cytotoxic Agents that Act by a New Mechanism of Action

  • Original language description

    Our study demonstrates that four novel kinetically inert C,N-cyclometalated Ru-II complexes of the type [Ru(C<^>N)(N<^>N)(2)][PF6] containing a handle for functionalization on the C<^>N ligand are very potent cytotoxic agents against several different human cancer cell lines and are up to 400-fold more potent than clinically used cisplatin. In addition, the investigated ruthenium complexes are less cytotoxic in noncancerous cells, and exhibit higher selectivity for cancer cells than conventional platinum anticancer drugs. The high potency of the investigated ruthenium compounds can be attributed to several factors, including enhanced internalization and their capability to change mitochondrial transmembrane potential in cells. The new ruthenium complexes also interfere with protein synthesis with a markedly higher potency than conventional inhibitors of DNA translation. Notably, the latter mechanism has not been hitherto described for other cytotoxic Ru compounds and cisplatin.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10608 - Biochemistry and molecular biology

Result continuities

  • Project

    <a href="/en/project/GA17-05302S" target="_blank" >GA17-05302S: Targeting cancer stem cells by antitumor metallodrugs. Studies on mechanism of action</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2017

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Chemistry - A European Journal

  • ISSN

    0947-6539

  • e-ISSN

  • Volume of the periodical

    23

  • Issue of the periodical within the volume

    61

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    5

  • Pages from-to

    15294-15299

  • UT code for WoS article

    000414351400006

  • EID of the result in the Scopus database